clarithromycin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SH; Kim, YC; Lee, JH; Lee, MG | 1 |
| Komori, T; Maruyama, T; Nonaka, A; Otagiri, M | 1 |
2 other study(ies) available for clarithromycin and Alloxan Diabetes
| Article | Year |
|---|---|
Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus.
Topics: Alloxan; Animals; Anti-Bacterial Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP3A; Diabetes Mellitus, Experimental; Enzyme Induction; Rats; Streptozocin | 2005 |
Effect of clarithromycin on alpha1-acid glycoprotein levels in normal and diabetic rats.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Dexamethasone; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypnotics and Sedatives; Injections, Subcutaneous; Male; Orosomucoid; Phenobarbital; Rats; Rats, Wistar | 1998 |